Skip to main content
Premium Trial:

Request an Annual Quote

DNAStar Awarded SBIR Grant to Continue Development of Sequence Assembly and Analysis Software for Clinical Research

NEW YORK (GenomeWeb News) – Bioinformatics software firm DNAStar said today it received a Phase II Small Business Innovation Research Grant in support of R&D aimed at expanding the company's sequence assembly and analysis software.

The grant from the National Human Genome Research Institute will be used by the Madison, Wis.-based firm to build out the capabilities of its software from broad research use to the clinical research market.

DNAStar said that the grant will be used in the second phase of a project that was funded in 2012. The amount being awarded to the company for the project is for $963,000 over two years, DNAStar VP and GM Tom Schwei told GenomeWeb Daily News.

"There is a growing trend to consider analyzing genomic information as part of clinical studies, whether retrospectively or prospectively," Schwei said in a statement. "Increasingly, clinical researchers are seeing that including a genomic component to clinical research can uncover key information that is critical in moving a study forward. … As part of this grant research program, we will be collaborating with clinicians on several cancer studies to ensure our software fully meets their needs.”

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.